Download FREE Sample
Table of Contents
1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Market Estimation
1.4. Market Forecasting
2. Executive Summary
3. Market Overview
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.2. Industry Speaks
3.3. Key Market Trends
4. COVID-19 Impact on Continuous Renal Replacement Therapy
Market
5. Global Continuous Renal Replacement Therapy Market- Size
& Forecast (2026-2031), By Product
5.1. CRRT Systems
5.2. Dialysates and Replacement
Fluids
5.3. Disposables
5.4. Hemofilters
5.5. Bloodline Sets (Tubing Sets)
5.6. Other Disposables
6. Global Continuous Renal Replacement Therapy Market- Size
& Forecast (2026-2031), By Modality
6.1. Continuous Venovenous
Hemofiltration (CVVH)
6.2. Continuous Venovenous
Hemodiafiltration (CVVHDF)
6.3. Continuous Venovenous
Hemodialysis (CVVHD)
6.4. Slow Continuous
Ultrafiltration (SCUF)
7. Global Continuous Renal Replacement Therapy Market- Size
& Forecast (2026-2031), By Region
7.1. North America (U.S. &
Canada)
7.2. Europe (UK, Germany, France,
Italy, Spain, Rest of Europe)
7.3. Asia Pacific (China, India,
Japan, Rest of Asia Pacific)
7.4. Rest of the World (Latin
America, Middle East & Africa)
8. Competitive Landscape
8.1. Key Players and their
Competitive Positioning
8.1.1. Market Share Analysis
(2022)
8.1.2. Segment-wise Player
Mapping
8.2. Key Strategies Assessment,
By Player (2020-2022)
8.2.1. New Product & Service
Launches
8.2.2. Partnerships, Agreements,
& Collaborations
8.2.3. Geographic Expansion
9. Key Companies Scanned (Indicative List)
9.1. B. Braun
9.2. Baxter International
9.3. Medtronic
9.4. Nipro Corporation
9.5. Fresenius Medical Care AG
9.6. Asahi Kasei Medical Co. Ltd.
9.7. Medica S.p.A
9.8. Medical Components, Inc.
9.9. Infomed SA
9.10. Nikkiso Co., Ltd.
